Memory Loss in a Patient Treated with Fluoxetine

Annals of Pharmacotherapy

Volumn 37, Issue 12, 2003, Pages 1800-1803

  Joss, Jacqueline D ^a,c   Burton, Robert M ^a   Keller, Cecilia A ^b  

^a Good Samaritan Regional Medical Center   (United States)

^b Oregon State University Oregon Health Science University College of Pharmacy   (United States)

^c NONE   (United States)

Author keywords

Fluoxetine; Memory loss; Selective serotonin reuptake inhibitors

Indexed keywords

CIPROFLOXACIN; DIGOXIN; FLUOXETINE; FUROSEMIDE; ISOSORBIDE DINITRATE; LORATADINE; RABEPRAZOLE; SALBUTAMOL; SEROTONIN UPTAKE INHIBITOR; SPIRONOLACTONE; TRIAMCINOLONE ACETONIDE; WARFARIN;

AGED; AMNESIA; ANAMNESIS; ARTICLE; CASE REPORT; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; MEMORY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCORING SYSTEM; URINARY TRACT INFECTION;

AGED; AGED, 80 AND OVER; FEMALE; FLUOXETINE; HUMANS; MEMORY DISORDERS;

EID: 0345707607     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D154     Document Type: Article

References (33)

1. Larson EB, Kukull WA, Katzman RL. Cognitive impairment: dementia and Alzheimer's disease. Annu Rev Public Health 1992;13:431-49.
2. Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly. Incidence, prevention and management. Drug Safety 1999;21:101-22.
3. Package insert. Prozac (fluoxetine). Indianapolis: Eli Lilly, February 2001.
4. Package insert. Cipro (ciprofloxacin). West Haven, CT: Bayer Corporation, May 2002.
5. Segev S, Alkan M. Transient mental impairment associated with quinolone therapy (abstract). Rev Infect Dis 1988;10(suppl 1):S262.
6. Sacktor NC, Mayeux R. Symptoms of neurologic disorders. In: Bussy RK, ed. Merritt's textbook of neurology. Baltimore: Williams & Wilkins, 1995:1-8.
7. Victor M, Ropper AH. Dementia and the amnesic (Korsakoff) syndrome. In: Principles of neurology. New York: McGraw-Hill, 2001:444-63.
8. Mirow S. Cognitive dysfunction associated with fluoxetine (letter). Am J Psychiatry 1991;148:948-9.
9. Bradley SJ, Kulik L. Fluoxetine and memory impairment. J Am Acad Adolesc Psychiatry 1993;32:1078-9.
10. Bangs ME, Petti TA, Janus MD. Fluoxetine-induced memory impairment in an adolescent. J Am Acad Child Adolesc Psychiatry 1994;33:1303-6.
11. Singh R, Gupta A, Singh B. Acute organic brain syndrome after fluoxetine treatment (letter). Am J Psychiatry 1995;152:295-6.
12. Hall T, Barrera RD, Randon M. Reversible memory loss following treatment with fluoxetine: a case study. Behav Intervent 2000;15:217-24.
13. Legg JF, Stiff MP. Drug-related test patterns of depressed patients. Psychopharmacology (Berl) 1976;50(2):205-10.
14. Schatzberg AF, Cole JO, Blumer DP. Speech blockade: a tricyclic side effect. Am J Psychiatry 1978;135:600-1.
15. Pande AC, Sayler ME. Adverse events and treatment discontinuations in fluoxetine clinical trial. Int Clin Psychopharmacol 1993;8:267-9.
16. Moskowitz H, Burns M. The effect on performance of two antidepressants, alone and in combination with diazepam. Prog Neuropsychopharmacol Biol Psychiatry 1988;12:783-92.
17. Fudge JL, Perry PJ, Garvey MJ, Kelly MW. A comparison of the effects of fluoxetine and trazodone on the cognitive functioning of depressed outpatients. J Affect Disord 1990;18:275-80.
18. Taragano FE, Lyketsos CG, Mangone CA, Allegri RF, Comesana-Diaz E. A double-blind, randomized, fixed-dose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer's disease. Psychosomatics 1997;38:246-52.
19. Cassano GB, Puca F, Scapicchio PL, Trabucchi M, for the Italian Study Group on Depression in Elderly Patients. Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients. J Clin Psychiatry 2002;63:396-402.
20. Nebes RD, Pollock BG, Mulsant BH, Butters MA, Zmuda MD, Reynolds CF 3rd. Cognitive effects of paroxetine in older depressed patients. J Clin Psychiatry 1999;60(suppl 20):26-9.
21. Schmitt JA, Kruizinga MJ, Riedel WJ. Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors. J Psychopharmacol 2001;15:173-9.
22. Furlan PM, Kallan MJ, Ten Have T, Pollock BG, Katz I, Lucki I. Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers. Am J Geriatr Psychiatry 2001;9:429-38.
23. Harmer CJ, Bhagwagar Z, Cowen PJ, Goodwin GM. Acute administration of citalopram facilitates memory consolidation in healthy volunteers. Psychopharmacology 2002;163:106-10.
24. Fairweather DB, Ashford J, Hindmarch I. Effects of fluvoxamine and dothiepin on psychomotor abilities in healthy volunteers. Pharmacol Biochem Behav 1996;53:265-9.
25. Linnoila M, Stapletin JM, George DT, Lane E, Eckardt MJ. Effects of fluvoxamine, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers. J Clin Psychopharmacol 1993;13:175-80.
26. Package insert. Fluvoxamine maleate tablets. Morgantown, WV: Mylan Pharmaceuticals, October 2000.
27. Package insert. Paxil CR (paroxetine). Research Triangle Park, NC: GlaxoSmithKline, April 2002.
28. Package insert. Zoloft (sertraline). New York: Pfizer, October 2002.
29. Package insert. Celexa (citalopram). St. Louis: Forest Laboratories, August 2002.
30. Goodnick PJ, Goldstein BJ. Selective serotonin reuptake inhibitors in affective disorders - I. Basic pharmacology. J Psychopharmacol 1998;12(3 suppl B):S5-20.
31. Richardson JS, Keegan DL, Bowen RC, Blackshaw SL, Cebrian-Perez S, Dayal S, et al. Verbal learning by major depressive disorder patients using treatment with fluoxetine and amitriptyline. Int Clin Psychopharmacol 1994;9:35-40.
32. Luciana M, Collins PF, Depue RA. Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. Cerebral Cortex 1998;8:218-26.
33. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.